| Financial Year |
March 31 2023 |
| Monetary Funds |
12,614,375,988.22 |
| Held-for-trading Financial Assets |
60,174.37 |
| Notes Receivable |
879,702,570.09 |
| Accounts Receivable |
12,584,561,262.24 |
| Advances to Suppliers |
1,067,913,083.28 |
| Other Receivables |
245,524,846.09 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
5,126,724,223.71 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
12,597,298.52 |
| Other Current Assets |
666,235,894.89 |
| Total Current Assets |
33,791,405,194.36 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
88,323,477.66 |
| Long-term Equity Investment |
1,294,270,820.68 |
| Investment Properties |
5,243,274.04 |
| Fixed Assetes |
8,739,301,921.93 |
| Under-construction Projects |
1,590,619,784.33 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,000,550,853.58 |
| R&D expenses |
-- |
| Goodwill |
5,558,534.52 |
| Long-Term Deferred and Prepaid Expenses |
7,242,870.58 |
| Deferred Income Tax Assets |
847,414,170.04 |
| Other Non-Current Assets |
104,716,974.89 |
| Sub-Total of Non-Current Assets |
15,768,863,132.55 |
| Total Assets |
49,560,268,326.91 |
| Short-Term Loans |
3,301,524,231.64 |
| Trading Financial liabilities |
-- |
| Notes Payable |
4,075,776,245.41 |
| Accounts Payable |
4,387,629,702.66 |
| Accounts Received In Advance |
10,315,113.01 |
| Employee Compensation Payable |
241,579,223.10 |
| Taxes Payable |
542,282,610.03 |
| Interest Payable |
-- |
| Dividend Payable |
118,000,000.00 |
| Other payables |
259,297,693.21 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,324,669,183.85 |
| Other Current Liabilities |
242,365,607.75 |
| Sub-Total of Current Liabilities |
15,399,166,945.64 |
| Long-term Loans |
553,612,838.89 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
239,306,522.72 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
532,176,748.22 |
| Other Non-Current Liabilities |
15,000,000.00 |
| Sub-Total of Non-Current Liabilities |
1,685,006,113.47 |
| Total Liabilities |
17,084,173,059.11 |
| Paid-In Capital(Or Share Stock) |
3,412,949,652.00 |
| Capital Surplus |
11,258,406,753.86 |
| Surplus Reserve |
1,256,935,622.36 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
14,688,191,300.21 |
| Minority Stockholder's Interest |
1,338,155,560.07 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
31,137,939,707.73 |
| Owner's Equity（Stockholder's Equity） |
32,476,095,267.80 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
49,560,268,326.91 |
